Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enoxaparin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02206100
What this trial is testing

PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin

Who this might be right for
Healthy
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 40
Post-approval studies (Phase 4)UnknownNCT02342444
What this trial is testing

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

Who this might be right for
TraumaSurgeryDeep Vein Thrombosis (DVT)+1 more
Oregon Health and Science University 606
Large-scale testing (Phase 3)Study completedNCT00902928
What this trial is testing

A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery

Who this might be right for
Venous ThromboembolismArthroplasty, Replacement, Hip
Astellas Pharma Europe B.V. 1,992
Not applicableNot Yet RecruitingNCT07559643
What this trial is testing

The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.

Who this might be right for
Bariatric SurgeryAnti-Xa ActivityVTE (Venous Thromboembolism)+1 more
University College Dublin 180
Large-scale testing (Phase 3)UnknownNCT04408235
What this trial is testing

High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy

Who this might be right for
COVIDPneumonia, ViralCoagulation Disorder
Azienda Ospedaliero-Universitaria di Modena 300
Testing effectiveness (Phase 2)Study completedNCT02706249
What this trial is testing

Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients

Who this might be right for
Venous Thormboembolism
Dana-Farber Cancer Institute 50
Large-scale testing (Phase 3)Study completedNCT00152971
What this trial is testing

Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement

Who this might be right for
Arthroplasty, Replacement, KneeThromboembolism
Boehringer Ingelheim 2,615
Post-approval studies (Phase 4)Study completedNCT03158792
What this trial is testing

Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function

Who this might be right for
Venous ThromboembolismRenal Impairment
Lebanese American University 32
Large-scale testing (Phase 3)Study completedNCT02181998
What this trial is testing

A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital Setting

Who this might be right for
Myocardial Infarction
Boehringer Ingelheim 1,606
Testing effectiveness (Phase 2)Study completedNCT00908960
What this trial is testing

Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles

Who this might be right for
Advanced Pancreatic, Colon, Lung, Gastric and Ovarian Cancer
Beth Israel Deaconess Medical Center 70
Post-approval studies (Phase 4)Looking for participantsNCT07189897
What this trial is testing

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

Who this might be right for
Venous ThromboembolismHead and Neck Cancer
Kiranya Arnold 76
Not applicableStudy completedNCT06010446
What this trial is testing

Intravenous Continuous LMWH Seems to be Safe Alternative to UFH in VV ECMO Patients

Who this might be right for
Refractory Respiratory Failure
University Hospital, Motol 43
Not applicableEnded earlyNCT00836355
What this trial is testing

Enoxaparin and/or Minocycline in Acute Stroke

Who this might be right for
Acute Ischemic Stroke
NYU Langone Health 6
Testing effectiveness (Phase 2)Study completedNCT04402762
What this trial is testing

Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®

Who this might be right for
Enoxaparin
Universitas Indonesia 20
Large-scale testing (Phase 3)Study completedNCT00679588
What this trial is testing

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

Who this might be right for
Venous Thromboembolism
Sanofi 4,413
Testing effectiveness (Phase 2)Study completedNCT04640181
What this trial is testing

Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)

Who this might be right for
Covid19
St. David's HealthCare 150
Large-scale testing (Phase 3)Ended earlyNCT00680628
What this trial is testing

Clot Dissolving Treatment for Blood Clots in the Lungs

Who this might be right for
Pulmonary Embolism
Wake Forest University Health Sciences 83
Not applicableNot Yet RecruitingNCT07168005
What this trial is testing

Informative Video Before LMWH Postpartum - Randomized Controlled Trial

Who this might be right for
Venous Thromboembolism (VTE)Postpartum CareAnxiety
Wolfson Medical Center 160
Not applicableEnded earlyNCT00521885
What this trial is testing

Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients

Who this might be right for
Venous Thrombosis
Lehigh Valley Hospital 1
Large-scale testing (Phase 3)Ended earlyNCT00206089
What this trial is testing

Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events

Who this might be right for
Thromboembolism
AstraZeneca 3,300
Next Page